EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

New developments in management of gastrointestinal stromal tumors: regorafenib, the new player in the team

Anette Duensing, Sergei Boichuk, Jessica Rausch

Gastrointestinal Cancer: Targets and Therapy · 2013

DOI: 10.2147/gictt.s20679 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gastrointestinal Cancer: Targets and Therapy, 2013. Verfasst von Anette Duensing und 2 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Duensing, A., Boichuk, S., & Rausch, J. (2013). New developments in management of gastrointestinal stromal tumors: regorafenib, the new player in the team. Gastrointestinal Cancer: Targets and Therapy. https://doi.org/10.2147/gictt.s20679

Vancouver

Duensing A, Boichuk S, Rausch J. New developments in management of gastrointestinal stromal tumors: regorafenib, the new player in the team. Gastrointestinal Cancer: Targets and Therapy. 2013. doi:10.2147/gictt.s20679

BibTeX
@article{Duensing2013,
  author = {Duensing, Anette and Boichuk, Sergei and Rausch, Jessica},
  title = {New developments in management of gastrointestinal stromal tumors: regorafenib, the new player in the team},
  journal = {Gastrointestinal Cancer: Targets and Therapy},
  year = {2013},
  doi = {10.2147/gictt.s20679}
}
Kostenlos starten →